ENTX Earnings

Quarterly EPS
$-0.08
Q3 2024
$-0.06
Q4 2024
$-0.06
Q1 2025
$-0.06
Q2 2025
$-0.07
Q3 2025
$-0.06
Q4 2025
$-0.07
Q1 2026
$-0.14
Q2 2026
Latest RevenueN/A
Latest Net Income-7312000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.140-7312000—-133.3%
Q1 2026-$0.070-3505000-100.0%-16.7%
Q4 2025-$0.060-3016000-100.0%+0.0%
Q3 2025-$0.070-3200000-100.0%+12.5%
Q2 2025-$0.060-2656000-100.0%+0.0%
Q1 2025-$0.0642.0K-2567000—-20.0%
Q4 2024-$0.0682.0K-2358000—+14.3%
Q3 2024-$0.0842.0K-3021000—+0.0%
Q2 2024-$0.0657.0K-2145000——
Q1 2024-$0.050-2017000——
Q4 2023-$0.070-1995000——
Q3 2023-$0.080-2379000——
Entera Bio (ENTX) — Earnings